Tumor necrosis factor‐α synthesis inhibitor, 3,6′‐dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neurochemistry

• Publication date

  2011-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1471-4159.2011.07377.xPMID 21740439PMCID PMC3397686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Widespread Tau and Amyloid‐Beta Pathology Many Years After a Single Traumatic Brain Injury in Humans

  2012cited by this paper
• The Psychiatric Sequelae of Traumatic Injury

  2011cited by this paper
• Brain-Penetrating Tumor Necrosis Factor Decoy Receptor in the Mouse

  2011cited by this paper
• Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury

  2011cited by this paper
• Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

  2011cited by this paper
• Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation

  2011cited by this paper
• Cell death mechanisms and modulation in traumatic brain injury

  2011cited by this paper
• The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI)

  2011cited by this paper
• Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

  2011cited by this paper
• Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments

  2010cited by this paper
• Paradoxical False Memory for Objects After Brain Damage

  2010cited by this paper
• The Influence of Alcohol on Behavioral Recovery after mTBI in Mice

  2010influential reference
• The psychiatric sequelae of traumatic injury.

  2010cited by this paper
• Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?

  2010cited by this paper
• Inflammation in neuropsychiatric disease.

  2010cited by this paper
• Traumatic Brain Injury: An Overview of Pathobiology with Emphasis on Military Populations

  2010cited by this paper
• Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology.

  2010cited by this paper
• Perispinal etanercept: a new therapeutic paradigm in neurology

  2010cited by this paper
• Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins.

  2010cited by this paper
• Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.

  2010cited by this paper
• Genetic Analysis of the Role of Tumor Necrosis Factor Receptors in Functional Outcome after Traumatic Brain Injury in Mice

  2010cited by this paper
• What has inflammation to do with traumatic brain injury?

  2010cited by this paper
• The intricate involvement of the Insulin-like growth factor receptor signaling in mild traumatic brain injury in mice.

  2010cited by this paper
• The TNF superfamily in 2009: new pathways, new indications, and new drugs.

  2009cited by this paper
• A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.

  2009influential reference
• Biomarkers of Blast-Induced Neurotrauma: Profiling Molecular and Cellular Mechanisms of Blast Brain Injury

  2009cited by this paper
• Does neuroinflammation fan the flame in neurodegenerative diseases?

  2009cited by this paper
• Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.

  2009cited by this paper
• Galectin-3 mediates post-ischemic tissue remodeling.

  2009cited by this paper
• Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

  2009cited by this paper
• Thalidomide fails to be therapeutic following contusive spinal cord injury in rats.

  2009cited by this paper
• TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.

  2009cited by this paper
• Systemic inflammatory response following acute traumatic brain injury.

  2009cited by this paper
• Closed Head Injury in a Mouse Model Results in Molecular Changes Indicating Inflammatory Responses

  2009cited by this paper
• Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury.

  2009cited by this paper
• Syntheses of Aromatic Substituted 6′‐Thiothalidomides.

  2009influential reference
• Long‐term Psychiatric Outcomes Following Traumatic Brain Injury: A Review of the Literature

  2009cited by this paper
• Syntheses of Aromatic Substituted6′-Thiothalidomides

  2008influential reference
• Targeting mRNA stability arrests inflammatory bone loss.

  2008cited by this paper
• Minimal Traumatic Brain Injury Induce Apoptotic Cell Death in Mice

  2008cited by this paper
• The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair

  2008cited by this paper
• The Predictive Brain State: Timing Deficiency in Traumatic Brain Injury?

  2008cited by this paper
• Mechanisms of injury by explosive devices.

  2007cited by this paper
• The thalidomide saga.

  2007cited by this paper
• Thalidomide analogues as anticancer drugs.

  2007cited by this paper
• TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

  2007influential reference
• Apoptotic and behavioral sequelae of mild brain trauma in mice

  2007influential reference
• The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model

  2007cited by this paper
• Traumatic Brain Injury and Delayed Sequelae: A Review - Traumatic Brain Injury and Mild Traumatic Brain Injury (Concussion) are Precursors to Later-Onset Brain Disorders, Including Early-Onset Dementia

  2007cited by this paper
• Traumatic brain injury: assessment, resuscitation and early management.

  2007cited by this paper
• Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction.

  2006cited by this paper
• Effect of Thalidomide on the Expression of TNF-α m-RNA and Synthesis of TNF-α in Cells from Leprosy Patients with Reversal Reaction

  2006cited by this paper
• No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab

  2006cited by this paper
• Morphine protects for head trauma induced cognitive deficits in mice.

  2006cited by this paper
• Mild Traumatic Brain Injury Induces Persistent Cognitive Deficits and Behavioral Disturbances in Mice

  2005influential reference
• The Effect of Moderate to Severe Traumatic Brain Injury (TBI) on Different Aspects of Memory:A Selective Review

  2005cited by this paper
• IMiDs: a novel class of immunomodulators.

  2005cited by this paper
• Cell Death Mechanisms Following Traumatic Brain Injury

  2004cited by this paper
• Clinical Pharmacokinetics of Thalidomide

  2004cited by this paper
• Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases.

  2004cited by this paper
• Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice.

  2003influential reference
• Increased hippocampal uptake of tumor necrosis factor α and behavioral changes in mice

  2003cited by this paper
• Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity.

  2003influential reference
• Age-dependent synuclein pathology following traumatic brain injury in mice.

  2003cited by this paper
• Prenatal diagnosis of hereditary spastic paraplegia This article is a US Government work and is in the public domain in the USA.

  2001influential reference
• Experimental Closed Head Injury: Analysis of Neurological Outcome, Blood–Brain Barrier Dysfunction, Intracranial Neutrophil Infiltration, and Neuronal Cell Death in Mice Deficient in Genes for Pro-Inflammatory Cytokines

  2000cited by this paper
• Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment.

  1999cited by this paper
• Exacerbation of Damage and Altered NF-κB Activation in Mice Lacking Tumor Necrosis Factor Receptors after Traumatic Brain Injury

  1999cited by this paper
• Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury.

  1999influential reference
• Research report Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition

  1999cited by this paper
• Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

  1997influential reference
• Object recognition in mice: improvement of memory by glucose.

  1997cited by this paper
• Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.

  1996cited by this paper
• Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury

  1996cited by this paper
• Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue.

  1994cited by this paper
• Closed Head Injury Triggers Early Production of TNFα and IL-6 by Brain Tissue

  1994cited by this paper
• Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand.

  1993cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• A two-trial memory task with automated recording: study in young and aged rats.

  1992influential reference
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

  1991cited by this paper

• Natural compounds in neuroprotection and nervous system regeneration: a narrative review

  2025cites this paper
• Evolution of Axonal Injury in the Closed Head Impact Model of Engineered Rotational Acceleration in Adult Ferrets

  2025cites this paper
• Unlocking therapeutic potential in traumatic brain injury: exploring microenvironmental targets, signaling pathways and translational hurdles

  2025cites this paper
• Clinical Management in Traumatic Brain Injury

  2024cites this paper
• Weight-drop model as a valuable tool to study potential neurobiological processes underlying behavioral and cognitive changes secondary to mild traumatic brain injury.

  2023cites this paper
• Regulatory T lymphocytes in traumatic brain injury.

  2023cites this paper
• Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs

  2022cites this paper
• Paired Associates Learning is Disrupted After Unilateral Parietal Lobe Controlled Cortical Impact in Rats: A Trial-by-Trial Behavioral Analysis

  2022cites this paper
• N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

  2021cites this paper
• Examining the association between traumatic brain injury and headache.

  2021cites this paper
• Ketogenic Diet as a potential treatment for traumatic brain injury in mice

  2021cites this paper
• Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice.

  2021cites this paper
• Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders

  2021cites this paper
• Repetitive Mild Traumatic Brain Injury and Transcription Factor Modulation

  2020cites this paper
• 3,6’-Dithiothalidomide Reduces Tinnitus Phenotype in Two Different Mouse Preclinical Models of Tinnitus

  2020cites this paper
• Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

  2020cites this paper
• Silymarin sex-dependently improves cognitive functions and alters TNF-α, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury.

  2020cites this paper
• 3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation

  2020cites this paper
• Pattern of head injuries in patients admitted in tertiary trauma Centre.

  2020cites this paper
• Chrysin attenuates traumatic brain injury-induced recognition memory decline, and anxiety/depression-like behaviors in rats: Insights into underlying mechanisms

  2020cites this paper
• A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats

  2019cites this paper
• Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats

  2019cites this paper
• Motor Effects of Minimal Traumatic Brain Injury in Mice

  2019cites this paper
• Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

  2019cites this paper
• Immunomodulatory drugs alleviate l‐dopa‐induced dyskinesia in a rat model of Parkinson's disease

  2019cites this paper
• (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.

  2019cites this paper
• Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary

  2019cites this paper
• Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer's disease.

  2019cites this paper
• Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

  2019cites this paper
• Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury

  2019cites this paper
• CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice

  2019cites this paper
• Anxiolytic‐ and antidepressant‐like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury

  2018influential citation
• Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury

  2018cites this paper
• Strides Toward Better Understanding of Post-Traumatic Headache Pathophysiology Using Animal Models

  2018cites this paper
• Comparison of Two Reagents for Thionations

  2018cites this paper
• Roles of Pro- and Anti-inflammatory Cytokines in Traumatic Brain Injury and Acute Ischemic Stroke

  2017cites this paper
• Immediate and delayed hyperbaric oxygen therapy as a neuroprotective treatment for traumatic brain injury in mice

  2017cites this paper
• Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine

  2017cites this paper
• Restorative effects of curcumin on sleep‐deprivation induced memory impairments and structural changes of the hippocampus in a rat model

  2017cites this paper
• Novel GLP‐1R/GIPR co‐agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury

  2017cites this paper
• Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration

  2017cites this paper
• Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury

  2017cites this paper
• Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.

  2016cites this paper
• Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents

  2016cites this paper
• Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.

  2016cites this paper
• Mild Concussion, but Not Moderate Traumatic Brain Injury, Is Associated with Long-Term Depression-Like Phenotype in Mice

  2016cites this paper
• Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms

  2016cites this paper
• Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with d-Cycloserine

  2016cites this paper
• Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI)

  2016cites this paper
• The Effects of Mild Concussions and Pomegranates on Behavior

  2016cites this paper
• Blast traumatic brain injury–induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon‐like peptide‐1 receptor agonist, exendin‐4

  2016cites this paper
• Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury

  2016cites this paper
• Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat

  2016cites this paper
• Treatment of traumatic brain injury with anti-inflammatory drugs.

  2016cites this paper
• Therapies negating neuroinflammation after brain trauma.

  2016cites this paper
• Dopamine Release Impairment in Striatum after Different Levels of Cerebral Cortical Fluid Percussion Injury

  2015cites this paper
• Emerging Therapies in Traumatic Brain Injury

  2015cites this paper
• A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the "post-inflammatory brain syndrome" PIBS.

  2015cites this paper
• Chronic Inflammation After TBI and Associated Behavioral Sequelae

  2015cites this paper
• Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice

  2015cites this paper
• Deficient Pain Modulatory Systems in Patients with Mild Traumatic Brain and Chronic Post-Traumatic Headache: Implications for its Mechanism

  2015cites this paper
• Neuroprotective effect of thalidomide on MPTP-induced toxicity.

  2015cites this paper
• Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice

  2015cites this paper
• Acute Response of the Hippocampal Transcriptome Following Mild Traumatic Brain Injury After Controlled Cortical Impact in the Rat

  2015cites this paper
• Tumor necrosis factor‐α potentiates long‐term potentiation in the rat dentate gyrus after acute hypoxia

  2015cites this paper
• Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury

  2014cites this paper
• Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

  2014cites this paper
• Current Understanding of Concussion: Treatment Perspectives

  2014cites this paper
• Temporal Course of Changes in Gene Expression Suggests a Cytokine-Related Mechanism for Long-Term Hippocampal Alteration after Controlled Cortical Impact

  2014cites this paper
• Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

  2014cites this paper
• HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice

  2014cites this paper
• Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

  2014influential citation
• Chronic post-traumatic headache: clinical findings and possible mechanisms

  2014cites this paper
• Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

  2014cites this paper
• Incretin mimetics as pharmacological tools to elucidate and as a new drug strategy to treat traumatic brain injury

  2014cites this paper
• Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

  2014influential citation
• Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury

  2014cites this paper
• RAMI Section of Biomedical Sciences: Annual Meeting 2012

  2013cites this paper
• Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

  2013influential citation
• Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.

  2013cites this paper
• Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice.

  2013cites this paper
• Cognitive Impairments Accompanying Rodent Mild Traumatic Brain Injury Involve p53-Dependent Neuronal Cell Death and Are Ameliorated by the Tetrahydrobenzothiazole PFT-α

  2013cites this paper
• Cytotoxicity of titanium dioxide nanoparticles in rat neuroglia cells

  2013cites this paper
• Treatment of Mild Traumatic Brain Injury with an Erythropoietin-Mimetic Peptide

  2013cites this paper
• Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats

  2013cites this paper
• Inflammatory Consequences in a Rodent Model of Mild Traumatic Brain Injury

  2013cites this paper
• 3,6′‐dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation

  2013cites this paper
• Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

  2012cites this paper
• NMDA preconditioning prevents object recognition memory impairment and increases brain viability in mice exposed to traumatic brain injury.

  2012cites this paper
• The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury.

  2012cites this paper
• 3,6′‐Dithiothalidomide, a new TNF‐α synthesis inhibitor, attenuates the effect of Aβ1–42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit

  2012cites this paper
• Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

  2012cites this paper
• Microenvironment changes in mild traumatic brain injury.

  2012cites this paper
• TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

  2012cites this paper
• New Hope for Survivors of Stroke and Traumatic Brain Injury

  2012cites this paper
• Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: the effect of minocycline.

  2012cites this paper
• Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice

  2012cites this paper
• Tumor necrosis factor-alpha synthesis inhibitor 3,6' -dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease

  2012influential citation
• Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation

  2011cites this paper
• Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

  2011cites this paper